Search hospitals > Tennessee > Nashville
Sarah Cannon Research Institute
Claim this profileNashville, Tennessee 37203
Global Leader in Tumors
Global Leader in Solid Tumors
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Breast Cancer
Conducts research for Cancer
670 reported clinical trials
27 medical researchers
Summary
Sarah Cannon Research Institute is a medical facility located in Nashville, Tennessee. This center is recognized for care of Tumors, Solid Tumors, Non-Small Cell Lung Cancer, Breast Cancer, Cancer and other specialties. Sarah Cannon Research Institute is involved with conducting 670 clinical trials across 285 conditions. There are 27 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and David R. Spigel, MD.Area of expertise
1Tumors
Global LeaderStage IV
Stage III
HER2 negative
2Solid Tumors
Global LeaderStage IV
Stage III
RET positive
Top PIs
Melissa Johnson, MDSarah Cannon Research Institute5 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Tumors
61 reported clinical trials
88 drugs studied
Erika P HamiltonSarah Cannon Research Institute4 years of reported clinical research
Expert in Breast Cancer
Expert in Ovarian Cancer
53 reported clinical trials
76 drugs studied
Meredith A McKeanSarah Cannon Research Institute1 year of reported clinical research
Expert in Solid Tumors
Expert in Tumors
34 reported clinical trials
66 drugs studied
David R. Spigel, MDTennessee Oncology3 years of reported clinical research
Expert in Non-Small Cell Lung Cancer
Expert in Tumors
29 reported clinical trials
54 drugs studied
Clinical Trials running at Sarah Cannon Research Institute
Breast Cancer
Non-Small Cell Lung Cancer
Solid Tumors
Tumors
Cancer
Colorectal Cancer
Multiple Myeloma
Ovarian Cancer
Lung Cancer
Lymphoma
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
Zanidatamab vs Trastuzumab
for Breast Cancer
The efficacy and safety of zanidatamab in combination with physician's choice of chemotherapy compared with trastuzumab in combination with physician's choice of chemotherapy will be evaluated for the treatment of participants with metastatic HER2-positive breast cancer who have progressed on, or are intolerant to, previous T-DXd treatment.
Recruiting2 awards Phase 34 criteria
PF-07220060
for Solid Cancers
This trial tests a new drug, PF-07220060, in patients with metastatic breast cancer. It aims to find the best dose and see if the drug helps stop cancer growth when used alone or with other treatments.
Recruiting1 award Phase 1 & 213 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Sarah Cannon Research Institute?
Sarah Cannon Research Institute is a medical facility located in Nashville, Tennessee. This center is recognized for care of Tumors, Solid Tumors, Non-Small Cell Lung Cancer, Breast Cancer, Cancer and other specialties. Sarah Cannon Research Institute is involved with conducting 670 clinical trials across 285 conditions. There are 27 research doctors associated with this hospital, such as Melissa Johnson, MD, Erika P Hamilton, Meredith A McKean, and David R. Spigel, MD.
Where is Sarah Cannon Research Institute located?
The Sarah Cannon Research Institute is located at 1100 Dr Martin L King Jr Blvd Ste 800, Nashville, TN. For driving directions, please use 250 25th Ave North, Nashville, TN as your destination.
Who should I call to ask about financial aid or insurance network?
For patient inquiries, contact the Sarah Cannon Research Institute at 615-342-1000. For specific financial concerns, reach out to Patient Account Services at 615-886-4733. The "askSARAH" service on their website also addresses frequently asked questions, including financial assistance topics.
What insurance does Sarah Cannon Research Institute accept?
Sarah Cannon Research Institute is a premier oncology research organization within HCA Healthcare. HCA Healthcare hospitals, including those affiliated with Sarah Cannon, accept most major health insurance plans in the Kansas City area. It is crucial to confirm that both the specific facility and your doctor accept your insurance plan before your visit.
What awards or recognition has Sarah Cannon Research Institute received?
Sarah Cannon Research Institute (SCRI) in Nashville, Tennessee, is a recognized strategic site and was named Clinical Trial Participation Award Recipient in 2015. SCRI has conducted over 600 first-in-human clinical trials. It has contributed to the majority of new cancer therapies approved by the FDA since its inception.